(TCAF) T. Rowe Price - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US87283Q8675

Large, U.S., Equities, Technology, Healthcare

Description: TCAF T. Rowe Price

The T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TCAF) is an ETF that primarily invests in equity securities, with a focus on large U.S. companies. The funds investment strategy is centered around capitalizing on growth opportunities in various sectors, with a notable emphasis on information technology and healthcare.

From a portfolio composition perspective, the fund is non-diversified, which means it may have a higher concentration of assets in a smaller number of holdings. This could potentially lead to increased volatility, but also presents opportunities for significant gains if the funds investments perform well. Key performance indicators (KPIs) to monitor for this fund include its tracking error relative to its benchmark, sector allocation, and stock selection.

In terms of key metrics, the funds Assets Under Management (AUM) stand at approximately $4.99 billion, indicating a sizable presence in the market. To further evaluate the funds performance, investors may want to examine its expense ratio, Sharpe ratio, and beta relative to its benchmark. Additionally, analyzing the funds holdings turnover and average market capitalization can provide insights into its investment strategy and potential risks.

To assess the funds potential for future growth, investors can examine its relative performance during different market cycles, as well as its ability to adapt to changing market conditions. By evaluating these factors, investors can gain a more comprehensive understanding of the funds strengths and weaknesses, and make more informed investment decisions.

TCAF ETF Overview

Market Cap in USD 5,441m
Category Large Blend
TER 0.31%
IPO / Inception 2023-06-14

TCAF ETF Ratings

Growth Rating 77.7%
Fundamental -
Dividend Rating 48.9%
Return 12m vs S&P 500 -3.93%
Analyst Rating -

TCAF Dividends

Dividend Yield 12m 0.41%
Yield on Cost 5y 0.57%
Annual Growth 5y 42.91%
Payout Consistency 100.0%
Payout Ratio %

TCAF Growth Ratios

Growth Correlation 3m 92.6%
Growth Correlation 12m 52.9%
Growth Correlation 5y 93.1%
CAGR 5y 18.45%
CAGR/Max DD 3y 1.13
CAGR/Mean DD 3y 19.24
Sharpe Ratio 12m 1.06
Alpha 0.00
Beta 0.814
Volatility 9.70%
Current Volume 837.8k
Average Volume 20d 877.7k
Stop Loss 35.9 (-3.2%)
Signal 0.05

What is the price of TCAF shares?

As of September 17, 2025, the stock is trading at USD 37.07 with a total of 837,811 shares traded.
Over the past week, the price has changed by +0.57%, over one month by +0.35%, over three months by +7.73% and over the past year by +14.06%.

Is T. Rowe Price a good stock to buy?

Yes. Based on ValueRay's Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (September 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.73 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TCAF is around 35.83 USD . This means that TCAF is currently overvalued and has a potential downside of -3.35%.

Is TCAF a buy, sell or hold?

T. Rowe Price has no consensus analysts rating.

What are the forecasts/targets for the TCAF price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 40.1 8.3%

Last update: 2025-09-06 04:49

TCAF Fundamental Data Overview

Market Cap USD = 5.44b (5.44b USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.44b USD (5.44b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 5.44b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.44b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(5.44b)/V(0.0) * Re(9.01%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for TCAF ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle